Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 June 2022 | Story Rulanzen Martin | Photo Sonia Small (Kaleidoscope Studios)
Dr Munyaradzi Mushonga is very optimistic about his appointment as the Global Academic Director of the Decolonial International Network.

Dr Munyaradzi Mushonga of the Centre for Gender and Africa Studies (CGAS) at the University of the Free State (UFS) has been appointed Global Academic Director of the Decolonial International Network (DIN). Dr Mushonga, who is a senior lecturer and programme director of CGAS’s Africa Studies programme, says his vision for DIN is “to work towards a new world civilisation that is opposed to the militarism and war, lawlessness and genocides of other civilisations.” 

Dr Mushonga, who is a leading voice and scholar on decolonialisation, will formally assume his role at DIN in 2023. 

The duality of new technology and scholarly work

Dr Mushonga says it is important for our minds to be decolonised, and he is therefore planning to establish a Centre for Decolonising The Mind (CDTM), which will use 21st-century technologies to achieve the ideal of decolonialisation. “Here pluriversal decolonial chapters and centres will be driven towards developing a decolonial history app,” he says. The aim is also to work towards a decolonial textbook on the history of Africa. 

He says it is commendable to employ technology to address decolonisation, but the real work to achieve the ideal of a decolonial mind lies in the scholarly work done by academics. At the CGAS the entire Africa Studies programme addresses decolonial theory and praxis through several approaches. “These are informed by our identity, which is anchored on two pillars, namely the interdisciplinary nature of all our engagements, as well as the exploration and critique of what it means to be ‘human’, but also in relation to the ‘non-human’ world.” He adds that the Centre’s teaching, supervision, and engagement with its students also challenges academics to think beyond the binaries of ‘coloniser’ and ‘colonised’, ‘white’ and ‘black’, and to reject all forms of fundamentalism. 

UFS’s commitment to decoloniality is a great asset 

Dr Mushonga's tenure at DIN will also reinforce the commitment to decolonial education made by the UFS, which has been noted by DIN. “I am convinced that DIN, the CGAS and the UFS can become the great vehicles to drive the decolonial agenda from the global South in general, and South Africa in particular,” he says. He says the commitment to the ideals of decolonisation displayed by UFS and the CGAS played a large part in his appointment to his new DIN role. 

The CGAS and the UFS will become key players in the DIN project, and Dr Mushonga hopes that more individuals and groups will come forward to join forces with DIN. “I hope this will enable DIN to push for new ethics in living.” 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept